Psychiatry and Neurology, Neurology · Boston, MA
NPI
1306810015
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
7
Hospital affiliations
55 Fruit Street, Vbk 915
Boston, MA, 02114
Phone (617) 726-3216
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
462 services
Medicare patients, 2024
159
Average age 69
Drug cost, 2024
$1.0M
875 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeremy Schmahmann was code G2212 (prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or), 284 times for 111 patients. In total Jeremy Schmahmann billed 462 services in 5 codes, and Medicare paid $34K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 284 | 111 | $26.68 | $7,576 |
| 99215 Office E&M - Established | Office | 143 | 128 | $139.37 | $20K |
| 99205 Office E&M - New | Office | 33 | 33 | $178.05 | $5,876 |
By year: 2022 $43K for 469 services; 2023 $38K for 519 services; 2024 $34K for 462 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeremy Schmahmann prescribed most often to Medicare patients was Riluzole, with 117 prescriptions and refills. In total Jeremy Schmahmann wrote 875 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Riluzole Generic | 117 | 271 | 31 | $15K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 67 | 151 | 16 | $1,333 |
| Clonazepam Generic | 56 | 96 | Under 11 | $1,234 |
| Primidone Generic | 52 | 113 | 13 | $1,527 |
| Baclofen Generic | 51 | 120 | 18 | $926 |
| Dalfampridine Er Dalfampridine | 50 | 105 | 12 | $7,413 |
| Citalopram Hbr Citalopram Hydrobromide | 49 | 114 | 13 | $153 |
| Trihexyphenidyl Hcl Generic | 41 | 86 | 12 | $937 |
| Gabapentin Generic | 28 | 67 | Under 11 | $395 |
| Amantadine Amantadine Hcl | 27 | 61 | Under 11 | $2,313 |
| Skyclarys Omaveloxolone | 26 | 31 | Under 11 | $985K |
| Memantine Hcl Generic | 20 | 34 | Under 11 | $655 |
| Methylphenidate Hcl Generic | 19 | 24 | Under 11 | $500 |
| Metoprolol Tartrate Generic | 17 | 45 | Under 11 | $116 |
| Levetiracetam Generic | 14 | 42 | Under 11 | $343 |
Brand drugs: - claims; generic drugs: 832 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeremy Schmahmann $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.